Sources

14 Total Sources

Vertex Buys Crinetics for $10 Billion, Paying 102% Premium to Expand Endocrinology

Left29%

Center57%

Right14%

Bloomberg6h ago

Vertex Pharmaceuticals to Acquire Crinetics for $10 Billion, Expanding Endocrinology Portfolio

Vertex to buy Crinetics for $10 billion in rare-diseases push | Reuters

Vertex to buy Crinetics in an all-cash deal valued at $10 billion

StockTitan6h ago

Vertex to Buy Crinetics for $10B in Cash | CRNX Stock News

Yahoo Finance6h ago

CRNX Stock Soars Nearly 100% After-Hours On Vertex's $10B Acquisition

Pulse 2.011h ago

Vertex Acquiring Crinetics Pharmaceuticals For $10 Billion

The Wall Street Journal6h ago

Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion - WSJ

Marketscreener.com6h ago

Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion | MarketScreener

Yahoo Canada Finance6h ago

Vertex to buy Crinetics for $10 billion to expand rare-disease business

Vertex to Acquire Crinetics Pharmaceuticals in $10 Billion Deal | citybiz

VRTX x $CRNX $XBI BREAKING: Vertex Pharmaceuticals Inc. agreed to buy Crinetics Pharmaceuticals Inc. for $10 billion in cash to expand into endocrinology, including medicines for acromegaly and hormone disorders. > The

M&A News: Vertex Stock (VRTX) Slips After Announcing the $10B Crinetics Acquisition - TipRanks.com

intellectia.ai9h ago

Vertex Acquires Crinetics for $10 Billion in Cash Deal | Intellectia.AI

Букви13h ago

Vertex announces deal to buy Crinetics for 10 billion dollars and gain Palsonify | Ukraine news - #Mezha